• Xarelto Class-Action Lawsuit Filed in Canada
  • March 23, 2015
  • Law Firm: Waters Kraus LLP - Dallas Office
  • A Canadian woman who nearly suffered a heart attack in 2012 as a result of internal bleeding that she developed while taking Xarelto has filed a class-action lawsuit in Calgary against Bayer Inc. A similar class-action will reportedly soon be filed in Ontario.

    Xarelto Said to Have Caused 12 Deaths in Canada Thus Far

    In Canada, Health Canada has received 1,100 reports of adverse effects connected to Xarelto. In 12 cases, death was reported.

    Xarelto is an anticoagulant used to prevent stroke in patients with atrial fibrillation. The drug has been aggressively marketed by Bayer as a replacement medication for Warfarin. The problem is that there is no antidote to stop bleeding when it occurs with patients taking Xarelto.

    A German report indicated that Xarelto has been linked to 130 deaths in 2012 and 2013.